Molecular diagnostics innovations
First real-time PCR assay for monitoring lung cancer patients
is now releasing the first real-time PCR assay for monitoring lung cancer patients eligible to the alternative treatment with Osimertinib (Tagrisso) due to acquired resistance to EGFR-tyrosine kinase inhibitor (TKI) therapy: EGFR T790M RealFast Assay.
Human DNA causes unspecific signals and an enormous loss of sensitivity during the PCR analysis of pathogen bacteria in clinical materials. With the MolYsis technology, quantitative human DNA is removed for more than 99% in all materials (tissue, blood, BAL, CSF, etc.)! More……
Request a Free Molysis Demo
- Removal of human DNA
- Enrichment of microbial (pathogen) DNA
- Fully automation possible (SelectNA Plus)
- Applicable for all materials
- Unique technology in molecular diagnostics
Taking Molecular Technology Personally
All the information on our website has been compiled with care and tailored as much as possible to developments in the market and in science. Should you nevertheless have ideas or suggestions with which we can further improve our service or our product portfolio, we would appreciate it if you let us know via email@example.com.